TenSixteen Bio (@tensixteenbio) 's Twitter Profile
TenSixteen Bio

@tensixteenbio

We are a biotechnology company leveraging somatic mosaicism and CHIP to transform the future of precision medicine in complex disease.

ID: 1442916951722889216

linkhttp://tensixteen.bio calendar_today28-09-2021 18:19:54

9 Tweet

319 Followers

3 Following

Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Announcing TenSixteen Bio!! 🎉 Thrilled to be a scientific co-founder with Alex Bick Siddhartha Jaiswal B. Ebert, along with founding advisors P. Libby & A. Tall. Spearheaded by M. Chao & his phenomenal team. tensixteen.bio Foresite Labs Foresite Capital GV

Announcing <a href="/tensixteenbio/">TenSixteen Bio</a>!! 🎉

Thrilled to be a scientific co-founder with <a href="/AlexBickMDPhD/">Alex Bick</a> <a href="/jaiswalmdphd/">Siddhartha Jaiswal</a> B. Ebert, along with founding advisors P. Libby &amp; A. Tall. 
Spearheaded by M. Chao &amp; his phenomenal team.

tensixteen.bio
<a href="/ForesiteLabs/">Foresite Labs</a> <a href="/ForesiteCapital/">Foresite Capital</a> <a href="/GVteam/">GV</a>
Alex Bick (@alexbickmdphd) 's Twitter Profile Photo

Excited to launch TenSixteen Bio today with fellow scientific co-founders Pradeep Natarajan, Siddhartha Jaiswal and Ben Ebert! Backed by Foresite Labs Foresite Capital GV and led by Mark Chao, we aspire to develop precision medicines to treat #CHIP. endpts.com/with-forty-sev…

Dr. Vik Bajaj (@vik_bajaj) 's Twitter Profile Photo

Foresite Labs just launched TenSixteen Bio, led by Mark Chao, with funding from Foresite Capital and GV. @TenSixteenBio is part of our commitment to address the root causes of common and complex diseases for which current treatments are inadequate. medium.com/tensixteen-bio…

Siddhartha Jaiswal (@jaiswalmdphd) 's Twitter Profile Photo

Today we launch TenSixteen Bio to advance the study of CHIP/somatic mosaicism. See eloquent Medium post below from CEO Mark Chao regarding our mission: to develop treatments that allow us to intervene at an earlier stage for deadly diseases.

Today we launch <a href="/tensixteenbio/">TenSixteen Bio</a> to advance the study of CHIP/somatic mosaicism. See eloquent Medium post below from CEO Mark Chao regarding our mission: to develop treatments that allow us to intervene at an earlier stage for deadly diseases.
TenSixteen Bio (@tensixteenbio) 's Twitter Profile Photo

One of our co-founders Pradeep Natarajan received the Jeffrey M. Hoeg Arteriosclerosis, Thrombosis and Vascular Biology Award for Basic Science and Clinical Research from American Heart Association . Congratulations Pradeep Natarajan! .